Recombinant human ACE2: acing out angiotensin II in ARDS therapy.
作者信息
Zhang Haibo, Baker Andrew
机构信息
Keenan Research Centre for Biomedical Science, St. Michael's Hospital, Room 619, LKSKI, 30 Bond Street, Toronto, ON, M5B 1W8, Canada.
Interdepartmental Division of Critical Care Medicine, Departments of Anesthesia and Physiology, University of Toronto, Toronto, ON, Canada.
出版信息
Crit Care. 2017 Dec 13;21(1):305. doi: 10.1186/s13054-017-1882-z.
Abstract
摘要
相似文献
1
Recombinant human ACE2: acing out angiotensin II in ARDS therapy.
Crit Care. 2017 Dec 13;21(1):305. doi: 10.1186/s13054-017-1882-z.
2
Angiotensin-converting enzyme 2 in acute respiratory distress syndrome.
Cell Mol Life Sci. 2007 Aug;64(15):2006-12. doi: 10.1007/s00018-007-6228-6.
3
Angiotensin-converting enzyme 2 (ACE2) in disease pathogenesis.
Circ J. 2010 Mar;74(3):405-10. doi: 10.1253/circj.cj-10-0045. Epub 2010 Feb 4.
4
Acute respiratory distress syndrome leads to reduced ratio of ACE/ACE2 activities and is prevented by angiotensin-(1-7) or an angiotensin II receptor antagonist.
J Pathol. 2011 Dec;225(4):618-27. doi: 10.1002/path.2987. Epub 2011 Oct 18.
5
[Local renin-angiotensin system disequilibrium and acute lung injury].
Sheng Li Ke Xue Jin Zhan. 2013 Apr;44(2):133-7.
6
Vitamin D alleviates lipopolysaccharide‑induced acute lung injury via regulation of the renin‑angiotensin system.
Mol Med Rep. 2017 Nov;16(5):7432-7438. doi: 10.3892/mmr.2017.7546. Epub 2017 Sep 20.
7
Alteration of the renin-angiotensin system in caerulein induced acute pancreatitis in the mouse.
Pancreatology. 2015 Nov-Dec;15(6):647-53. doi: 10.1016/j.pan.2015.09.007. Epub 2015 Sep 28.
8
[New regulator in renin angiotensin system: ACE2].
Sheng Li Ke Xue Jin Zhan. 2006 Apr;37(2):179-81.
9
[The importance of ACE2 in regulating the cardiovascular system].
Harefuah. 2007 Sep;146(9):703-6, 733.
10
A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome.
Crit Care. 2017 Sep 7;21(1):234. doi: 10.1186/s13054-017-1823-x.
引用本文的文献
1
The impact of diabetes and obesity on the severity and mortality of SARS-CoV-2 infection.
J Diabetes Metab Disord. 2025 Sep 1;24(2):195. doi: 10.1007/s40200-025-01706-5. eCollection 2025 Dec.
2
Substance P - a regulatory peptide with defense and repair functions. Results and perspectives for the fight against COVID-19.
Front Neurol. 2024 May 30;15:1370454. doi: 10.3389/fneur.2024.1370454. eCollection 2024.
3
ACE2: the node connecting the lung cancer and COVID-19.
Am J Cancer Res. 2024 Apr 15;14(4):1466-1481. doi: 10.62347/XJVE4569. eCollection 2024.
4
Genetic Variations in the Human Angiotensin-ConvertingEnzyme 2 and Susceptibility to Coronavirus Disease-19.
Genet Res (Camb). 2023 Nov 29;2023:2593199. doi: 10.1155/2023/2593199. eCollection 2023.
5
Estrogens as a Possible Therapeutic Strategy for the Management of Neuroinflammation and Neuroprotection in COVID-19.
Curr Neuropharmacol. 2023;21(10):2110-2125. doi: 10.2174/1570159X21666230616103850.
6
The Protective Potential Role of ACE2 against COVID-19.
Adv Virol. 2023 May 26;2023:8451931. doi: 10.1155/2023/8451931. eCollection 2023.
7
Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support-Free Days in Patients Hospitalized With COVID-19: A Randomized Clinical Trial.
JAMA. 2023 Apr 11;329(14):1183-1196. doi: 10.1001/jama.2023.4480.
8
S Protein, ACE2 and Host Cell Proteases in SARS-CoV-2 Cell Entry and Infectivity; Is Soluble ACE2 a Two Blade Sword? A Narrative Review.
Vaccines (Basel). 2023 Jan 17;11(2):204. doi: 10.3390/vaccines11020204.
9
The Role of Immunity in the Pathogenesis of SARS-CoV-2 Infection and in the Protection Generated by COVID-19 Vaccines in Different Age Groups.
Pathogens. 2023 Feb 15;12(2):329. doi: 10.3390/pathogens12020329.
10
Human ACE2 expression, a major tropism determinant for SARS-CoV-2, is regulated by upstream and intragenic elements.
PLoS Pathog. 2023 Feb 22;19(2):e1011168. doi: 10.1371/journal.ppat.1011168. eCollection 2023 Feb.
本文引用的文献
1
A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome.
Crit Care. 2017 Sep 7;21(1):234. doi: 10.1186/s13054-017-1823-x.
2
Angiotensin-(1-5), an active mediator of renin-angiotensin system, stimulates ANP secretion via Mas receptor.
Peptides. 2016 Dec;86:33-41. doi: 10.1016/j.peptides.2016.09.009. Epub 2016 Sep 20.
3
Therapeutic time window for angiotensin-(1-7) in acute lung injury.
Br J Pharmacol. 2016 May;173(10):1618-28. doi: 10.1111/bph.13462. Epub 2016 Mar 21.
4
Mechanical Stress and the Induction of Lung Fibrosis via the Midkine Signaling Pathway.
Am J Respir Crit Care Med. 2015 Aug 1;192(3):315-23. doi: 10.1164/rccm.201412-2326OC.
5
Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections.
Nat Commun. 2014 May 6;5:3594. doi: 10.1038/ncomms4594.
6
Angiotensin signalling in pulmonary fibrosis.
Int J Biochem Cell Biol. 2012 Mar;44(3):465-8. doi: 10.1016/j.biocel.2011.11.019. Epub 2011 Nov 30.
7
Acute respiratory distress syndrome leads to reduced ratio of ACE/ACE2 activities and is prevented by angiotensin-(1-7) or an angiotensin II receptor antagonist.
J Pathol. 2011 Dec;225(4):618-27. doi: 10.1002/path.2987. Epub 2011 Oct 18.
8
Heterogeneous distribution of angiotensin I-converting enzyme (CD143) in the human and rat vascular systems: vessel, organ and species specificity.
Microvasc Res. 2011 Mar;81(2):206-15. doi: 10.1016/j.mvr.2010.12.003. Epub 2010 Dec 16.
9
The growth factor midkine regulates the renin-angiotensin system in mice.
J Clin Invest. 2009 Jun;119(6):1616-25. doi: 10.1172/JCI37249. Epub 2009 May 18.
10
Angiotensin converting enzyme 2 is primarily epithelial and is developmentally regulated in the mouse lung.
J Cell Biochem. 2007 Aug 1;101(5):1278-91. doi: 10.1002/jcb.21248.
Zotero 插件